Circuits regulating pleasure and happiness in major depression

Medical Hypotheses

Volumn 87, Issue , 2016, Pages 14-21

  Loonen, A J M ^a   Ivanova, S A ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NATIONAL RESEARCH TOMSK POLYTECHNIC UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

AMYGDALOID NUCLEUS; ANHEDONIA; ANXIETY DISORDER; ARTICLE; BASAL GANGLION; BEHAVIOR; CAUDATE NUCLEUS; COGNITION; DYSPHORIA; EMOTION; EXTRAPYRAMIDAL SYSTEM; HAPPINESS; HOPELESSNESS; HUMAN; LIMBIC SYSTEM; MAJOR DEPRESSION; MISERY FLEEING SEEKING BEHAVIOR; MONOAMINERGIC SYSTEM; MOTIVATION; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; NUCLEUS ACCUMBENS CORE; NUCLEUS ACCUMBENS SHELL; PLEASURE; PUTAMEN; REWARD; REWARD SEEKING BEHAVIOR; SEROTONINERGIC SYSTEM; STRIA TERMINALIS; BIOLOGICAL MODEL; DEPRESSIVE DISORDER, MAJOR; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL MODEL; PSYCHOLOGY;

DEPRESSIVE DISORDER, MAJOR; EXTRAPYRAMIDAL TRACTS; HAPPINESS; HUMANS; LIMBIC SYSTEM; MODELS, NEUROLOGICAL; MODELS, PSYCHOLOGICAL; NEURAL PATHWAYS; PLEASURE; SEROTONIN UPTAKE INHIBITORS;

EID: 84955611266     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2015.12.013     Document Type: Article

References (58)

1. Wikipedia. (consulted on 4 May 2015). http://en.wikipedia.org/wiki/Anhedonia.
2. Klein D.F., Gittelman R., Quitkin F., Rifkin A. Diagnosis and drug treatment of psychiatric disorders: adults and children 1980, Williams and Wilkins, Baltimore, MD, USA. 2nd ed.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1980, American Psychiatric Association, Washington, DC, USA. 3rd ed.
4. Baldwin D.S., Anderson I.M., Nutt D.J., et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2005, 19(6):567-596.
5. Belzer K., Schneier F.R. Comorbidity of anxiety and depressive disorders: issues in conceptualization, assessment, and treatment. J Psychiatr Pract 2004, 10(5):296-306.
6. Hettema J.M. What is the genetic relationship between anxiety and depression?. Am J Med Genet Part C Semin Med Genet 2008, 148C(2):140-146.
7. Van Praag H.M. Anxiety/aggression-driven depression. Prog Neuro-Psychopharmacol Biol Psychiatry 2001, 25(1):893-924.
8. Van Loo H.M., De Jonge P., Romeijn J.W., Kessler R.C., Schoevers R.A. Data-driven subtypes of major depressive disorder: a systematic review. BMC Med 2012, 10:156.
9. Leventhal A.M., Rehm L.P. The empirical status of melancholia: implications for psychology. Clin Psychol Rev 2005, 25(1):25-44.
10. Loonen A.J., Ivanova S.A. Circuits regulating pleasure and happiness: the evolution of reward-seeking and misery-fleeing behavioral mechanisms in vertebrates. Front Neurosci 2015, 9:394. 10.3389/fnins.2015.00394.
11. Robertson B., Kardamakis A., Capantini L., Pérez-Fernández J., Suryanarayana S.M., Wallén P., et al. The lamprey blueprint of the mammalian nervous system. Prog Brain Res 2014, 212:337-349. 10.1016/B978-0-444-63488-7.00016-1.
12. O'Rahilly R., Müller F. The embryonic human brain. An atlas of developmental stages 2006, Willey-Liss, Hoboken, NJ, USA. 3rd ed.
13. Sewards T.V., Sewards M.A. Representations of motivational drives in mesial cortex, medial thalamus, hypothalamus and midbrain. Brain Res Bull 2003, 61(1):25-49.
14. Verret L., Fort P., Gervasoni D., Léger L., Luppi P.H. Localization of the neurons active during paradoxical (REM) sleep and projecting to the locus coeruleus noradrenergic neurons in the rat. J Comp Neurol 2006, 495(5):573-586.
15. Suckow S.K., Deichsel E.L., Ingram S.L., Morgan M.M., Aicher S.A. Columnar distribution of catecholaminergic neurons in the ventrolateral periaqueductal gray and their relationship to efferent pathways. Synapse 2013, 67(2):94-108.
16. Braz J.M., Enquist L.W., Basbaum A.I. Inputs to serotonergic neurons revealed by conditional viral transneuronal tracing. J Comp Neurol 2009, 514(2):145-160.
17. Cameron A.A., Khan I.A., Westlund K.N., Cliffer K.D., Willis W.D. The efferent projections of the periaqueductal gray in the rat: a Phaseolus vulgaris-leucoagglutinin study. I. Ascending projections. J Comp Neurol 1995, 351(4):568-584.
18. Lightman S.L. The neuroendocrinology of stress: a never ending story. J Neuroendocrinol 2008, 20(6):880-884.
19. Liotti M., Panksepp J. Imaging human emotions and affective feelings: implications for biological psychiatry. Textbook of biological psychiatry 2004, 33-74. Wiley-Liss, Hoboken, NJ, USA. J. Panksepp (Ed.).
20. Berridge K.C., Robinson T.E., Aldridge J.W. Dissecting components of reward: 'liking', 'wanting', and learning. Curr Opin Pharmacol 2009, 9(1):65-73.
21. Berridge K.C. From prediction error to incentive salience: mesolimbic computation of reward motivation. Eur J Neurosci 2012, 35(7):1124-1143.
22. Balleine B.W., Killcross S. Parallel incentive processing: an integrated view of amygdala function. Trends Neurosci 2006, 29(5):272-279.
23. Morrison S.E., Salzman C.D. Re-valuing the amygdala. Curr Opin Neurobiol 2010, 20(2):221-230.
24. Kelley A.E. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev 2004, 27(8):765-776.
25. Cardinal R.N. Neural systems implicated in delayed and probabilistic reinforcement. Neural Netw 2006, 19(8):1277-1301.
26. Berridge K.C., Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res Brain Res Rev 1998, 28(3):309-369.
27. Bromberg-Martin E.S., Matsumoto M., Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 2010, 68(5):815-834.
28. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35(4):217-238.
29. Gregg T.R., Siegel A. Brain structures and neurotransmitters regulating aggression in cats: implications for human aggression. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25(1):91-140.
30. Davis M., Walker D.L., Miles L., Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 2010, 35(1):105-135.
31. Misslin R. The defense system of fear: behavior and neurocircuitry. Neurophysiol Clin 2003, 33(2):55-66.
32. Myers-Schulz B., Koenigs M. Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders. Mol Psychiatry 2012, 17(2):132-141.
33. Berkowitz R.L., Copland J.D., Reddy D.P., Gorman J.M. The human dimension: how the prefrontal cortex modulates the subcortical fear response. Rev Neurosci 2007, 18(3-4):191-207.
34. Sotres-Bayon F., Bush D.E., LeDoux J.E. Emotional perseveration: an update on prefrontal-amygdala interactions in fear extinction. Learn Mem 2004, 11(5):525-535.
35. Bruinsma F., Loonen A.J. Neurobiologie van cognitieve en emotionele motivatie. Neuropaxis 2006, 10(3):77-86.
36. Freese J.L., Amaral D.G. Neuroanatomy of the primate amygdala. The human amygdala 2009, Guildford Press, New York, NY, USA, 3-42. P.J. Whalen, E.A. Phelps (Eds.).
37. Pitkänen A. Connectivity of the rat amygdaloid complex. The Amygdala. A functional analysis 2000, Oxford University Press, Oxford, UK, 31-115. J.P. Aggleton (Ed.).
38. Heimer L. A new anatomical framework for neuropsychiatric disorders and drug abuse. Am J Psychiatry 2003, 160(10):1726-1739.
39. Elias W.J., Ray D.K., Jane J.A. Lennart Heimer: concepts of the ventral striatum and extended amygdala. Neurosurg Focus 2008, 25(1):E8.
40. Mayberg H.S. Defining the neuronal circuitry of depression: toward a new nosology with therapeutic implications. Biol Psychiatry 2007, 61(6):729-730.
41. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003, 65(1):193-207.
42. Seminowicz D.A., Mayberg H.S., McIntosh A.R., et al. Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 2004, 22(1):409-418.
43. Loonen A.J.M. Are SSRIs true antidepressant drugs? A plea for the re-evaluation of their therapeutic potential and safety. Pharm World Sci 1997, 19(2):70-72.
44. Den Boer J.A., Westenberg H.G. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol 1988, 3(1):59-74.
45. Loonen AJM. Five theories of the mechanism of depression. Paper presented at: CINP International Education Course Modern Problems of the Neurobiology of Depression; 13 May 2013; Tomsk, Siberia, RF & 17 May 2013; Novosibirsk, Siberia, RF.
46. Loonen A.J., Ivanova S.A. New insights into the mechanism of drug-induced dyskinesia. CNS Spectr 2013, 18(1):15-20.
47. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986, 9:357-381.
48. Groenewegen H.J. The ventral striatum as an interface between the limbic and motor systems. CNS Spectr 2007, 12(12):887-892.
49. Dalley J.W., Mar A.C., Economidou D., Robbins T.W. Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav 2008, 90(2):250-260.
50. Loonen A.J., Stahl S.M. The mechanism of drug-induced akathisia. CNS Spectr 2011, 16(1):7-10.
51. Herrero M.T., Barcia C., Navarro J.M. Functional anatomy of thalamus and basal ganglia. Childs Nerv Syst 2002, 18(8):386-404.
52. Nieuwenhuys R. The insular cortex: a review. Prog Brain Res 2012, 195:123-163.
53. Hamani C., Mayberg H., Stone S., Laxton A., Haber S., Lozano A.M. The subcallosal cingulate gyrus in the context of major depression. Biol Psychiatry 2011, 69(4):301-308.
54. van Waarde A., Vaalburg W., Doze P., Bosker F.J., Elsinga P.H. PET imaging of beta-adrenoceptors in human brain: a realistic goal or a mirage?. Curr Pharm Des 2004, 10(13):1519-1536.
55. Anand A., Charney D.S. Norepinephrine dysfunction in depression. J Clin Psychiatry 2000, 61(Suppl. 10):16-24.
56. Den Boer J.A., Westenberg H.G., Kamerbeek W.D., Verhoeven W.M., Kahn R.S. Effect of serotonin uptake inhibitors in anxiety disorders; a double blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacol 1987, 2(1):21-32.
57. Millan M.J. Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie 2005, 60(5):441-460.
58. Sinclair L.I., Christmas D.M., Hood S.D., Potokar J.P., Robertson A., Isaac A., et al. Antidepressant-induced jitteriness/anxiety syndrome: systematic review. Br J Psychiatry 2009, 194(6):483-490.